NextPlat Corp. (NASDAQ:NXPL – Get Free Report) was the target of a significant decline in short interest during the month of December. As of December 15th, there was short interest totaling 199,110 shares, a decline of 32.5% from the November 30th total of 294,871 shares. Approximately 1.4% of the company’s shares are short sold. Based on an average daily trading volume, of 217,370 shares, the short-interest ratio is currently 0.9 days. Based on an average daily trading volume, of 217,370 shares, the short-interest ratio is currently 0.9 days. Approximately 1.4% of the company’s shares are short sold.
Institutional Investors Weigh In On NextPlat
A hedge fund recently bought a new stake in NextPlat stock. Citadel Advisors LLC acquired a new position in NextPlat Corp. (NASDAQ:NXPL – Free Report) during the third quarter, according to the company in its most recent disclosure with the SEC. The firm acquired 48,176 shares of the company’s stock, valued at approximately $40,000. Citadel Advisors LLC owned 0.19% of NextPlat as of its most recent SEC filing. Institutional investors own 1.30% of the company’s stock.
Analyst Upgrades and Downgrades
Separately, Weiss Ratings reaffirmed a “sell (d-)” rating on shares of NextPlat in a research note on Monday, December 22nd. One research analyst has rated the stock with a Sell rating, According to MarketBeat.com, the company has an average rating of “Sell”.
NextPlat Stock Down 4.8%
Shares of NASDAQ NXPL traded down $0.03 on Wednesday, hitting $0.53. The company had a trading volume of 116,388 shares, compared to its average volume of 327,117. The company has a quick ratio of 2.80, a current ratio of 3.56 and a debt-to-equity ratio of 0.04. NextPlat has a 12-month low of $0.43 and a 12-month high of $2.30. The firm has a market capitalization of $14.05 million, a P/E ratio of -1.78 and a beta of 1.16. The business has a 50 day moving average of $0.68 and a two-hundred day moving average of $0.73.
NextPlat (NASDAQ:NXPL – Get Free Report) last released its quarterly earnings results on Wednesday, November 12th. The company reported ($0.08) EPS for the quarter. NextPlat had a negative return on equity of 34.22% and a negative net margin of 14.58%.The company had revenue of $13.75 million for the quarter.
NextPlat Company Profile
NextPlat Corp operates as a healthcare and e-commerce company in Europe, North America, South America, the Asia and Pacific, and Africa. The company operates full-service retail specialty services pharmacies that provides prescription pharmaceuticals prescription pharmaceuticals, third-party administration, risk and data management services, compounded medications, tele-pharmacy services, anti-retroviral medications, medication therapy management, contracted pharmacy services, and health practice risk management to healthcare organizations and providers, as well as supplies prescription medications to long-term care facilities.
Read More
- Five stocks we like better than NextPlat
- Do not delete, read immediately
- The Crash Has Already Started (Most Just Don’t See It Yet)
- ALERT: Drop these 5 stocks before January 2026!
- [No Brainer Gold Play]: “Show me a better investment.”
- INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off
Receive News & Ratings for NextPlat Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NextPlat and related companies with MarketBeat.com's FREE daily email newsletter.
